Cralgo
Questions shaping technology in Pharma.
Pharma institutions are being re-priced by the depth of their intelligence about molecule, trial, market and outcome.
Industry context · Pharma
Pharma institutions are being re-priced by the depth of their intelligence about molecule, trial, market and outcome.
Industry Overview
Pharma institutions are being re-priced by the depth of their intelligence about molecule, trial, market and outcome.
Current Signals · Trends
AI-assisted discovery; real-world evidence; outcome-led pricing.
Current Signals · Customer Behaviour
Payers and providers expect outcome evidence.
Current Signals · Technology Evolution
AI in discovery; real-world evidence platforms; unified molecule-to-market spine.
Current Signals · AI Adoption
Discovery, trial design, real-world evidence.
Current Signals · Execution Patterns
Cross-function briefs across discovery, trial and market.
Common Challenges
Discovery, trial and market intelligence held in separate institutions inside the same firm.
Areas to Examine
Unified molecule-to-market intelligence; AI inside discovery and evidence; cross-function decision cadence.
Related
How Pharma connects across Cralgo Knowledge and Evidence
Knowledge · Architectures
Evidence · Field Notes
We identify emerging patterns and opportunities through research and Signals, and take them into real-world application through technology strategy and leadership, AI and data, digital commerce and consumer platforms, product and engineering, and technology-led growth and transformation.
From emerging patterns to real-world application.
Emerging Patterns → Research & Signals → Collaborate → Technology & Application → Better Outcomes
Where we apply this thinking
Technology Strategy & Leadership · AI & Data · Digital Commerce · Consumer Platforms · Product & Engineering · Technology-led Growth & Transformation
Psychology × Technology × Organisations → Outcomes — the research lens Cralgo explores through.
Explore Signals · Collaborate with Cralgo
Signals · What is a Signal? · Open Signals · Threads · Papers · Reflections · Field Notes · Questions · What we are learning · Research · Technology · Open Explorations · Collaborations · Evidence · About Cralgo · Beyond · Connect
Founding
Cralgo was founded in 2025 by Anil Kabir Kumar. Legal entity: Cralgo Innovations (OPC) Private Limited, incorporated 27 June 2025.
The three lenses
Psychology — how people perceive, decide and behave. Technology — what the system makes possible or constrains. Organisations — what conditions shape action. Outcomes emerge from their interaction.
Research — the questions underneath the work
Collaborative investigation with organisations, universities, practitioners and the people a question affects. Commissioned research is disclosed as such.
Beyond — questions Cralgo carries on its own account
Beyond describes the origin of a question: one Cralgo carries independently, or around a public-purpose context.
- Beyond
- Explore
- Beyond Ecosystem
- AI and public purpose — a provisional context inside Beyond
- Cralgo Now — a public-interest initiative about timing and attention
Working together — the belief behind all of it
Listening before concluding, room for different perspectives, useful disagreement, and evidence that still matters.